Literature DB >> 11817606

Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al.

YoussefBenHadj Hmida, Patrick Schmit, Georges Gilson, René-Louis Humbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11817606     DOI： 10.1002/1529-0131(200201)46:1<280::AID-ART10079>3.0.CO;2-A

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  4 in total

1.  Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Authors:  R Cervera; O Viñas; M Ramos-Casals; J Font; M García-Carrasco; A Sisó; F Ramírez; Y Machuca; J Vives; M Ingelmo; R W Burlingame
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

2.  Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus.

Authors:  Adel A Shabana; Atef E El-Ghawet; Shereen A Machaly; Ekbal M Abu Hashim; Basma A El-Kady; Reham Shaat
Journal:  Clin Rheumatol       Date:  2009-03-14       Impact factor: 2.980

3.  Anti-nucleosome antibody in sclerodema patients.

Authors:  Francisco Gustavo Mendes E Ferreira de Araujo; Thelma Larocca Skare; Renato M Nisihara; Shirley R Utiyama
Journal:  Indian J Med Res       Date:  2011-03       Impact factor: 2.375

Review 4.  The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.

Authors:  Sonal Mehra; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-03       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.